For those of us that are in US, a potentially significant Pharma tariff was just announced by Pres Trump.
As you know many of the Pca meds we take are not made in the US, including, I believe, the ones I take: relugolix and daralutamide. I anticipate the typical response of: ask your dr for potential alternatives. For many of us the alternatives would be less effective or not work. In my case I failed on xtandi and erleada.
Also, what about psma scans and treatments? Will we be affected by this tariff for this key process for our advanced Pca case?
The enormous cost of these drugs ,especially as many are taken monthly, potentially for years, would be crippling.
There may be some very wealthy members in our group that can cover these costs, but most would not be able to sustain such an enormous cost drain.
Comments?